Alector secures flexible credit facility for up to $50 million from hercules capital

South san francisco, calif., nov. 14, 2024 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the company has entered into a debt financing agreement with hercules capital, inc. (nyse: htgc) for up to $50 million.
ALEC Ratings Summary
ALEC Quant Ranking